A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia
Journal of the American Society of Nephrology · 2026-05 · 37 (5) · 944-958
DOI: 10.1681/asn.0000000942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 25.11.2025. Verfasst von Chuan Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Cilia, TRPP Cation Channels, Phosphoric Monoester Hydrolases, Phosphatidylinositols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Baltimore PKD Center, U.S. Department of Defense.
Abstract (Originalsprache)
Key Points Inositol polyphosphate-5-phosphatase E (INPP5E) and type Ig phosphatidylinositol-4-phosphate 5-kinase (PIPKIγ) coordinated the homeostasis of phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate in primary cilia. Modulating INPP5E or PIPKIγ activity changed the level of polycystin-1 and polycystin-2 in primary cilia. INPP5E inhibition increased the hypomorphic PKD1 variants (PC1-R3277C) in cilia and reduced cystogenesis in the kidney in vitro .
Background
Autosomal dominant polycystic kidney disease is mainly caused by mutations in PKD1 and PKD2 , which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. PC1 and PC2 assemble a cation channel complex enriched in primary cilium, a sensory organelle associated with various developmental diseases, including polycystic kidney disease (PKD). Accumulating evidence supports the necessity of functional polycystin (PC) complex in cilia to prevent cystogenesis in the kidney, indicating that improving their ciliary levels may ameliorate defects underlying PKD pathogenesis. Yet, molecular mechanisms underlying the ciliary targeting and homeostasis of the PC complex are not fully understood.
Methods
Indirect immunofluorescence microscopy was used to monitor ciliary levels of PC1 and PC2 in renal epithelial cells. Electrophysiology analysis in oocytes was used to determine the channel activity of the PC complex. Cystogenesis in the kidney was measured using in vitro 3D-Matrigel cell models and ex vivo mouse embryonic kidney models.
Results
Suppressing inositol polyphosphate-5-phosphatase E (INPP5E) or activating type Ig phosphatidylinositol-4-phosphate 5-kinase raised ciliary levels of the PC complex in both normal renal epithelial cells and cells carrying autosomal dominant polycystic kidney disease mutations that interrupt the trafficking of PCs into cilia, including GANAB inactivation and the trafficking PKD1 mutation p.Arg3277Cys (RC). PC1 RC formed a complex with PC2 and exhibited normal channel activity in vitro . An INPP5E that increases PC1 and PC2 in cilia, suppressed in vitro forskolin-induced cystogenesis of inner medullary collecting duct epithelial cell line 3 cells in 3D Matrigel and ex vivo cyst formation in embryonic Pkd1 RC/RC mouse kidneys.
Conclusions
Our results demonstrated that increasing the ciliary level of PCs, by manipulating a ciliary phosphoinositide signaling axis, enhanced the functionality of PCs and suppressed cystogenesis of renal epithelial cells in vitro .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
- Department of Biological Sciences, St. John's University, New York, New York.
- Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
ORCID-Profile: Chuan Chen, Zhifei Wang, Madilyn R Ellis, Biyun Ji, Cynthia J Sieben, Mandy Croyle, Qingwen Xu, Kai He, Yan Huang, Bradley K Yoder, Peter C Harris, Yong Yu, Kun Ling
Förderung
- NIDDK NIH HHS
- Baltimore PKD Center
- U.S. Department of Defense
- U54 center grant to Maryland PKD Research and Translation Core Center
- Pilot and Feasibility sub-awards from Mayo Clinic Translational PKD Center
- Center for Individualized Medicine, Mayo Clinic
- NIA NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Chen, C., Wang, Z., Gao, Y., Ellis, M. R., Ji, B., Sieben, C. J., Haycraft, C. J., Croyle, M., Aghevli, A., Xu, Q., Robichaud, J. H., He, K., Chen, C., Huang, Y., Yoder, B. K., Hu, J., Harris, P. C., Yu, Y., & Ling, K. (2026). A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia. Journal of the American Society of Nephrology, 37(5), 944-958. https://doi.org/10.1681/asn.0000000942
Vancouver
Chen C, Wang Z, Gao Y, Ellis MR, Ji B, Sieben CJ, et al. A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia. Journal of the American Society of Nephrology. 2026;37(5):944-958. doi:10.1681/asn.0000000942
BibTeX
@article{Chen2026,
author = {Chen, Chuan and Wang, Zhifei and Gao, Yue and Ellis, Madilyn R and Ji, Biyun and Sieben, Cynthia J and Haycraft, Courtney J and Croyle, Mandy and Aghevli, Ariana and Xu, Qingwen and Robichaud, Jielu H and He, Kai and Chen, Chunhua and Huang, Yan and Yoder, Bradley K and Hu, Jinghua and Harris, Peter C and Yu, Yong and Ling, Kun},
title = {A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {5},
pages = {944--958},
doi = {10.1681/asn.0000000942}
}
EUVIMED